Healthcare Industry Thought Leadership

Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions. Check out our latest thought leadership pieces below.

Building Relationships vs. Publishing Content: Reflecting on the Renewed Interest In Migraine Disease

June 1, 2018

A new class of migraine drugs, called anti-CGRPs (calcitonin gene-related peptide) are expected to reinvigorate a market that has been largely dormant for some time. Four biopharma companies, Amgen, Teva, Lilly and Alder are entering the fray. Not surprisingly, the intense competition and pharma investment associated with this market dynamic has led traditional “eyeball driven” publishers, like WebMD, Everyday Health and others on a quest to offer substantially more migraine-related content in reaction to this market opportunity.

What People Fear the Most About Their Future With Asthma

May 31, 2018

"Asthma In America 2018" asked questions about diagnosis, medications, treatments and more to over 800 respondents. Surprisingly, the survey revealed four things people with asthma fear most about their future, all of which have a profound impact on the way they view their condition and rate their quality of life.

The High Cost of Living with Inflammatory Bowel Disease

May 24, 2018

IBD In America 2018, a recent survey conducted by Health Union, revealed that 41% of people with inflammatory bowel disease (IBD) say their household finances are significantly impacted by the out-of-pocket costs associated with their condition.

An iceberg is seen both above and below the water.

Cancer, Connections, Community: The art of bringing people together

May 23, 2018

Getting any type of diagnosis is life-changing. When that diagnosis is the “C” word, there’s a heaviness that raises a whole range of emotions and questions often relating more to mortality than morbidity--not to mention there can also be a fair amount of guilt associated with survival. While great strides have been made in the availability and effectiveness of cancer treatments, the psychosocial aspect associated with having cancer hasn’t kept pace.

Long-Term Business Vision: Importance for Growth

June 29, 2019

Many digital health companies are driven financially by short-term gains. Read why that’s less impactful than following a long-term business vision.

WHITEPAPER: Patient Interest and Participation in Clinical Trials

June 21, 2019

Health Union compiled data from more than 21,000 respondents to examine factors involved in patients’ interest and participation in clinical research.

Biologic Usage and Psoriasis Patients: What’s the barrier?

June 13, 2019

Many people living with psoriasis still do not use biologics, but those who do show greater HCP satisfaction and condition control.

David Shronk, Health Union’s SVP of Media, Recognized Among 2019 PM360 ELITE

May 16, 2019

PM360, the premier information resource for marketing decision makers in the pharmaceutical, biotech and medical device sectors, has named David Shronk, Health Union’s senior vice president of media, as one of the 2019 PM360 ELITE 100 in the Sales MVP category.

Healthcare Industry Thought Leadership

Contact